This page includes the latest FDA filings for Seattle Genetics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | SGEN | DUNS 028484371 |
Device Company | Device | Date |
|---|---|---|
| SEAGEN INC. | Prescription Medication | 2024-11-05 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2024-10-04 |
| SEAGEN INC. | Prescription Medication | 2024-09-15 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2024-09-01 |
| SEAGEN INC. | Prescription Medication | 2024-07-04 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2023-12-30 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2023-09-16 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2023-06-27 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2023-05-04 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2023-04-29 |
| SEAGEN INC. | Prescription Medication | 2023-02-04 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2022-11-19 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2022-11-13 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2022-08-31 |
| SEAGEN INC. | Prescription Medication | 2022-03-26 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2022-02-25 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2021-12-16 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2021-11-25 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2021-07-20 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2021-07-01 |
| SEAGEN INC. | Prescription Medication | 2021-06-02 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2021-04-08 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2020-12-17 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2020-11-06 |
| SEAGEN INC. | Prescription Medication | 2020-05-02 |
| Seattle Genetics, Inc. | TUKYSA | 2020-04-17 |
| Seattle Genetics, Inc. | TUKYSA | 2020-04-17 |
| SEAGEN INC., Astellas Pharma US, Inc. | Prescription Medication | 2020-01-01 |
| Seattle Genetics, Inc. | PADCEV | 2019-12-18 |
| Seattle Genetics, Inc. | PADCEV | 2019-12-18 |
| SEAGEN INC., PIERRE FABRE MEDICAMENT PRODUCTION, BSP Pharmaceuticals Srl, Covance Laboratories, Baxter Oncology GmbH | Prescription Medication | 2019-10-29 |
| Seattle Genetics, Inc. | 2017-09-22 | |
| Seattle Genetics, Inc. | 2011-08-25 | |
| Seattle Genetics, Inc. | 2011-08-25 | |
| Seattle Genetics, Inc. | ADCETRIS | 2011-08-25 |
| NCAGE Code | 6PZ43 | SEATTLE GENETICS, INC. |
| CAGE Code | 6PZ43 | SEATTLE GENETICS, INC. |
| S.A.M. Registration | 6PZ43 [28484371] | SEATTLE GENETICS, INC. |
| DUNS | 028484371 | Seattle Genetics, Inc. |